Agilent Technologies Inc (A)vsElevance Health Inc (ELV)
A
Agilent Technologies Inc
$117.69
+0.14%
HEALTHCARE · Cap: $32.36B
ELV
Elevance Health Inc
$374.71
+1.53%
HEALTHCARE · Cap: $80.93B
Smart Verdict
WallStSmart Research — data-driven comparison
Elevance Health Inc generates 2737% more annual revenue ($200.42B vs $7.07B). A leads profitability with a 18.3% profit margin vs 2.6%. A appears more attractively valued with a PEG of 1.20. A earns a higher WallStSmart Score of 61/100 (C+).
A
Buy61
out of 100
Grade: C+
ELV
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-46.1%
Fair Value
$88.23
Current Price
$117.69
$29.46 premium
Margin of Safety
+63.5%
Fair Value
$1011.48
Current Price
$374.71
$636.77 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 20 in profit
Strong operational efficiency at 22.9%
Large-cap with strong market position
Attractively priced relative to earnings
Reasonable price relative to book value
Generating 4.1B in free cash flow
Areas to Watch
Moderate valuation
Grey zone — moderate risk
Weak financial health signals
Earnings declined 3.6%
2.6% revenue growth
2.6% margin — thin
Weak financial health signals
Earnings declined 16.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Return on Equity, Operating Margin. Profitability is solid with margins at 18.3% and operating margin at 22.9%. PEG of 1.20 suggests the stock is reasonably priced for its growth.
Bull Case : ELV
The strongest argument for ELV centers on Market Cap, P/E Ratio, Price/Book. PEG of 1.43 suggests the stock is reasonably priced for its growth.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : ELV
The primary concerns for ELV are Revenue Growth, Profit Margin, Piotroski F-Score. Thin 2.6% margins leave little buffer for downturns.
Key Dynamics to Monitor
A profiles as a mature stock while ELV is a value play — different risk/reward profiles.
A carries more volatility with a beta of 1.30 — expect wider price swings.
A is growing revenue faster at 7.0% — sustainability is the question.
ELV generates stronger free cash flow (4.1B), providing more financial flexibility.
Bottom Line
A scores higher overall (61/100 vs 56/100), backed by strong 18.3% margins. ELV offers better value entry with a 63.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Elevance Health Inc
HEALTHCARE · HEALTHCARE PLANS · USA
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?